Clinical trials: sponsored by GE Healthcare
Computed Tomography
Next Generation CT System
The purpose of the study is to collect data to evaluate utility of a next generation CT system in a clinical setting.
- Trial name
- NCT06769594
- Testing
- Investigational CT Scan
- Where
- United States
- Volunteers
- 64 people
- Sponsor
- GE Healthcare
CT Photon Counting
Clinical Data Collection On Advanced CT System
The purpose of the study is to evaluate the investigational Edge-on Silicon Photon Counting CT device in a clinical setting.
- Trial name
- NCT05835284
- Testing
- Investigational Edge-on Silicon Photon Counting CT device
- Where
- Sweden
- Volunteers
- 76 people
- Sponsor
- GE Healthcare
Healthy Volunteers
A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers
This is a Phase 1, single-center, open-label, single-arm, dose-escalation positron emission tomography study to assess the safety and tolerability, immunogenicity, Pharmacokinetics, dosimetry, and biodistribution after GEH200521…
- Trial name
- NCT06398730
- Testing
- GEH200520 Injection and GEH200521 (18F) Injection, Static - PET/CT scan
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Focal Liver Lesions
Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
Liver tumours, 40% of which are benign, account for 1% to 4% of all solid tumours in children. The benign tumours are mainly haemangiomas, liver hamartomas, and liver cell adenomas.
- Trial name
- NCT06639828
- Testing
- Contrast-Enhanced Ultrasound
- Where
- 6 sites in Germany, Italy and 1 more
- Volunteers
- 50 people
- Sponsor
- GE Healthcare
Pregnancy
Maternal Fetal Device Performance Singleton
Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which supports the decision making for pregnant women and the overall fetal health…
- Trial name
- NCT06726343
- Testing
- Fetal Monitoring Device, Investigational Fetal Monitoring Device
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- GE Healthcare
CT Photon-Counting
Spectral CT With Advanced CT Technology
The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.
- Trial name
- NCT04781296
- Testing
- CT with a photon-counting detector
- Where
- Sweden
- Volunteers
- 30 people
- Sponsor
- GE Healthcare
Parkinson Disease, Essential Tremor
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
Clinical study to demonstrate an at least equivalent performance of a new PET molecular Imaging radiopharmaceutical named [18F] LBT-999 in brain imaging compared to the SPECT reference method named [123I]-FP-CIT to establish the…
- Trial name
- NCT04265209
- Testing
- SPECT, PET
- Where
- 16 sites in France
- Volunteers
- 152 people
- Sponsor
- GE Healthcare
Breast Cancer
Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer
The study described in this protocol is a Phase 1, single center clinical trial to evaluate the safety and potential of [18F]GEH121224 as a PET radiotracer for the diagnostic imaging of HER2 positive breast cancer lesions.
- Trial name
- NCT05634954
- Testing
- GEH121224 (18F) Injection, Dynamic and Static - PET/CT Scan, Static - PET/CT Scan
- Where
- United States
- Sponsor
- GE Healthcare
Lung Disease, Lung Ultrasound
Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath
This is a prospective, non-randomized clinical validation research study. Subjects will consent and have two ultrasounds as part of the study.
- Trial name
- NCT07046234
- Testing
- Lung ultrasound
- Where
- 3 sites in United States
- Volunteers
- 150 people
- Sponsor
- GE Healthcare
Echocardiography
Clinical Performance Evaluation of a Diagnostic Ultrasound System
Subjects who are required to undergo transesophageal echocardiography according to the current clinical practice standards will be eligible for enrollment.
- Trial name
- NCT07066449
- Where
- China
- Volunteers
- 60 people
- Sponsor
- GE Healthcare
Metastatic Breast Cancer
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
This is a multi-center study in France to evaluate the impact of ESTROTEP PET/CT results on the therapeutic management of patients with metastatic breast cancer (MBC).
- Trial name
- ESTROTIMP (NCT05486182)
- Testing
- 18F Fluoroestradiol Radiopharmaceutical with PET/CT
- Where
- 11 sites in France
- Volunteers
- 153 people
- Sponsor
- GE Healthcare
Parkinson Disease, Movement Disorders
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease. This study determined if a lower dose (5 millicuries) would suffice.
- Trial name
- NCT05636852
- Testing
- Altropane (123I) Injection
- Where
- 4 sites in United States
- Volunteers
- 15 people
- Sponsor
- GE Healthcare
Fetal Monitoring
Evaluation of the Goldcrest Patch Performance
The Novii Patch is an accessory to the Novii+ Pod that connects directly to the Novii+ Pod and contains the surface electrodes that attach to the abdomen.
- Trial name
- NCT06355453
- Testing
- Goldcrest Patch and Three Patch Coupons, Goldcrest Patch and Novii Patch
- Where
- United States
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Blood Pressure, Blood Pressure Measurement
NIBP Cuff Comparison Study
The purpose of the study is to compare NIBP cuff materials and their effect on the measurement results.
- Trial name
- NCT07024472
- Where
- 2 sites in Finland
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Surgery, Intensive Care
CARESCAPE Monitoring Systems ME Study
Improving the reliability and accuracy of the current parameter measurement technologies is always based on measurement data to develop a newer generation.
- Trial name
- NCT07024459
- Testing
- Monitoring
- Where
- Finland
- Volunteers
- 80 people
- Sponsor
- GE Healthcare
SpO2, Peripheral Oxygen Saturation Measurement
Wireless Disposable SpO2 Sensor Hypoxia Testing
The purpose of the study is to collect SpO2 data with simultaneous transfer standard SpO2 measurements data on human participants.
- Trial name
- SpO2 Dispo (NCT06211530)
- Testing
- SpO2 Sensor Testing
- Where
- United States
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- GE Healthcare
Chronic Coronary Syndrome, Coronary Artery Disease
Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
The primary objective of this study is to assess the accuracy in terms of sensitivity, specificity, negative and positive predicted values of the DL-based algorithm with respect to correct identification of the plaque and…
- Conditions
- Chronic Coronary Syndrome, Coronary Artery Disease, Stable Angina, Acute Coronary Syndrome
- Trial name
- FOCUS DL (NCT06186336)
- Testing
- Deep Learning-based Vulnerable Plaque Detection and Assessment Tool
- Where
- Italy
- Volunteers
- 200 people
- Sponsor
- GE Healthcare
Intubation, Tracheostomy
Carbon Dioxide Investigation
The investigational device enables monitoring of EtCO2, FiCO2 and respiration rate values. The purpose of this clinical study is to collect parameter raw data for development, evaluate the operational and functional features of…
- Conditions
- Intubation, Tracheostomy, Laryngeal Mask
- Trial name
- NCT06715410
- Testing
- CO2
- Where
- Finland
- Volunteers
- 42 people
- Sponsor
- GE Healthcare
Cognitive Impairment
A Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in Europe
This is a study to determine the effectiveness of the VIZAMYL™ reader training programme in clinical practice in Europe
- Trial name
- NCT04773015
- Where
- 10 sites in Austria, Finland and 3 more
- Volunteers
- 227 people
- Sponsor
- GE Healthcare
Metastatic Breast Cancer
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
This is a phase 4, multi-center, open-label, prospective cohort study to evaluate the clinical utility of Fluoroestradiol F18 (Cerianna) PET/CT to guide therapeutic management in ER-positive, HER2-negative metastatic breast…
- Trial name
- NCT05068726
- Testing
- 18F Fluoroestradiol Radiopharmaceutical with PET/CT
- Where
- 24 sites in United States
- Volunteers
- 51 people
- Sponsor
- GE Healthcare